Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot.
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender